We are building:

CaniSense Light

CaniSense Light is our fast and affordable first-line cancer screening test for dogs. It is designed primarily for routine check-ups of older or higher-risk dogs, including animals that appear healthy and show no obvious signs of cancer.

Using a simple blood sample, CaniSense Light analyses biological patterns in circulating DNA that may indicate an increased cancer risk. Because it requires less genomic data than our comprehensive test, it can provide results faster and at a lower cost.

The goal is to help answer an important first question:

“Does this dog show a cancer-related signal that should be investigated further?”

CaniSense Light does not aim to determine the exact cancer type. Instead, it provides an accessible first step that can help veterinarians decide whether additional investigation is appropriate. It can also support repeated, tumour-agnostic monitoring when changes over time are more important than identifying a specific tumour type.

CaniSense

CaniSense provides a deeper and more comprehensive analysis. It examines more information from the DNA fragments circulating in the dog's blood and combines these signals using bioinformatics and AI.

Cancer can leave measurable changes in circulating DNA. CaniSense is designed to recognise several of these signals together, helping veterinarians assess whether cancer may be present and providing more detailed information to support cancer classification and further diagnostic decisions.

The result is delivered as a veterinary report and is intended to complement—not replace—the clinical examination, medical history, imaging, pathology and other diagnostic information available to the veterinarian.

In simple terms:

CaniSense Light asks: “Is there a cancer-related signal we should investigate?”

CaniSense asks: “What more can we learn about that signal?”